Target intelligence / Profile preview

Argininosuccinate synthetase 1 pseudogene 6 (ASS1P6)

Target
ASS1P6
Molecular classification
Other (Pseudogene)
01

Overview

Argininosuccinate synthetase 1 pseudogene 6 (ASS1P6) is classified as a pseudogene and does not encode a functional protein product. Pseudogenes are gene sequences that resemble functional genes but are typically non-coding due to mutations or lack of regulatory elements. ASS1P6 is related by sequence similarity to the protein-coding gene argininosuccinate synthetase 1 (ASS1), which plays a key role in the urea cycle and arginine biosynthesis, but ASS1P6 itself does not perform these enzymatic or receptor functions[5]. ASS1P6 is specifically described in genetic databases as a pseudogene, lacking protein-coding function and not associated with canonical molecular targets such as enzymes, receptors, or transporters[5]. Its nomenclature and aliases reflect its origin as a nonfunctional duplicate or processed fragment of the functional ASS1 gene[5]. There is no evidence or literature to support a therapeutic, diagnostic, or biomarker role for ASS1P6. ASS1P6 is not listed as a disease gene, is not targeted by drugs, and has no described mechanism of action, safety profile, or biological/pathophysiological function. This pseudogene should not be confused with argininosuccinate synthase 1 (ASS1), which is a validated therapeutic and biomarker target. No spelling or information errors were found with the designation of ASS1P6, but its lack of function means it is outside the scope of therapeutic target research[5].

Other names
ASSP6argininosuccinate synthetase pseudogene 6

Beyond the preview

Go deeper on Argininosuccinate synthetase 1 pseudogene 6 (ASS1P6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Argininosuccinate synthetase 1 pseudogene 6 (ASS1P6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call